Skip to main content Presents the DayOne Acceleration Program Supported by Fondation Botnar

| News Presents the DayOne Acceleration Program Supported by Fondation Botnar


Seeking brilliant project ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people. Selected projects will receive up to 70,000 CHF in non-dilutive funding.

DayOne, the swiss innovation hub for precision medicine and digital health run by, is launching an acceleration program supported by Fondation Botnar. Applications are now open to project ideas improving the wellbeing and health of children and adolescents worldwide.

The acceleration program will include a tailor-made mentoring program, access to DayOne industry experts and collaborative workspace at the DayOne Lab. Selected projects will receive up to 70,000 CHF in non-dilutive funding. We are looking for brilliant ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people.

The program welcomes healthcare innovators, start-ups and entrepreneurs as well as intrapreneurs willing to accelerate their project outside of their corporate environment.

We at DayOne believe that healthcare is moving from the hospital to the living room and changing from a sick repair system to a health system. Therefore, Fondation Botnar through the DayOne Acceleration program is reaching out to healthcare innovators who are passionate about developing new approaches to improve the wellbeing and health of children and adolescents around the world in any setting. The solutions should have a strong impact delivering health outcomes, while being cost-efficient, scalable and sustainable.

The program will support teams and individuals who strive to:

  • go beyond research and create minimal viable healthcare products and services
  • target health Issues with a special focus on pediatrics and/or adolescents
  • enable frontline work to deliver better health outcomes
  • lower the healthcare costs and be scalable and therefore making their solution suitable for all markets including in emerging countries.

The solutions should embrace a human centric approach focusing on young people and make appropriate use of Digital Technologies (Mobile Apps, AI, Blockchain etc.)

Participants will have the opportunity to drive their project idea forward in a collaborative way engaging with the healthcare innovation ecosystem of the Basel Region. Applicants should therefore be willing to be present in the Basel region and be able to dedicate sufficient personal time to execute on their idea during the six-month period of the DayOne Acceleration Program.

The deadline for the initial application is July 31st.

An initial selection of projects will be made in early August. The selected projects will participate at the DayOne conference on September 11th in Basel where they will receive valuable feedback on their project idea from healthcare innovation experts. They will then have 3 weeks to complete a final application by September 30 th. The formal acceleration program will start no later than January 14 th 2019 and be for a period of 6 months.

Registration and more information

Get involved now, fill out the application.
For more Information, please see our FAQs.

About Fondation Botnar

Fondation Botnar is a charitable foundation established with the core purpose to support children’s basic needs throughout the world. It was founded in Basel in 2003 to continue the philanthropic work of the Botnar family. Its focus is health, nutrition and education.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Why CDMO companies choose the Basel Area as their location

Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...
Read More

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...
Read More

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...
Read More

RocketVax raises fresh capital

The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...
Read More

Clinerion is now part of Citeline

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read More

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read More

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read More

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read More

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read More

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read More

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read More

BSI integrating AI from Parashift in banking software

Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read More

UptownBasel joins IBM Quantum Network

UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read More

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...
Read More

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...
Read More

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...
Read More

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...
Read More

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...
Read More

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...
Read More

Do you have a question? We'd like to hear from you.